"The Pink Sheet"  "The Gray Sheet"  "The Tan Sheet"  Other FDC Pubs.    "The Pink Sheet" PharmAsia News "The Pink Sheet" DAILY "The Gray Sheet" "The Tan Sheet" "The Rose Sheet" "The Gold Sheet" "The Silver Sheet" Pharmaceutical Approvals Health News Daily FDAAdvisoryCommittee
		search within: All Publications Medicare Drug Focus "The Blue Sheet" "The Gold Sheet" "The Gray Sheet" Medicare Guide "The Pink Sheet" "The Pink Sheet DAILY" "The Rose Sheet" "The Silver Sheet" "The Tan Sheet" Health News Daily Pharmaceutical Approvals Research Policy ALERT Washington Fax   A D V E R T I S E M E N T  May 9, 2008 Volume 20, Number 91  Daily Content from Elsevier Global Medical News Spray Recombinant Human Thrombin Controls Bleeding, Minimally Immunogenic Chicago — Spray recombinant human thrombin achieved hemostasis within 20 minutes in 91.5% of patients following burn wound excision in a prospective, phase II safety study in 71 patients.   READ MORE>> Daily News from "The Gray Sheet" Medtronic Recalls Certain Disposables Made With Contaminated Heparin Safety concerns surrounding the anticoagulant drug heparin have moved more squarely into the device space with the “precautionary” recall of selected Medtronic products coated with the Carmeda BioActive surface.   READ MORE>> News from "The Pink Sheet" DAILY AstraZeneca Submits First Atypical Antipsychotic For Anxiety Indication AstraZeneca submitted an sNDA May 7 for Seroquel XR (quetiapine fumarate) for generalized anxiety disorder, which, if approved, would be the first atypical antipsychotic marketed for the indication.   READ MORE>> Daily news from "The Tan Sheet" FDA Works To Ease “Traumatic” Advisory Committee Process – Ganley Recognizing the advisory committee meeting process can be “traumatic” for both government and industry, FDA is taking steps to improve the process and quality of panelists’ decision-making, said Charles Ganley, director of FDA’s Office of Nonprescription Products at the Center for Drug Evaluation and Research.   READ MORE>>

© 2008 FDC Reports | Privacy Policy | Terms of Use
	FDC Reports is the publisher of "The Pink Sheet"; "The Pink Sheet" DAILY; "The Gray Sheet"; FDAAdvisoryCommittee.com; "The Tan Sheet"; "The Rose Sheet"; Pharmaceutical Approvals Monthly; "The Gold Sheet"; "The Silver Sheet"; Health News Daily; PharmAsia News, an Elsevier company.